MEDICOX Co., Ltd. Extraordinary meeting approves name change to CHOONGANG OCEAN, rejects head office move
MAI summary · Not investment advice
Shareholders of MEDICOX Co., Ltd. approved a company name change and other items at an extraordinary meeting. The election of one inside director, a head office move and an articles amendment were rejected.
Key facts
- Meeting date
- Oct 15, 2026
- Agenda item 1
- Approval of the 28th fiscal year financial statements — ApprovedOrdinary resolution · 99.6% of shares voted in favor
- Agenda item 2
- Approval of the director pay limit — ApprovedOrdinary resolution · 99.6% in favor · limit KRW 1.5 billion
- Agenda item 3
- Approval of the auditor pay limit — ApprovedOrdinary resolution · 99.6% in favor · limit KRW 100.0 million
- Voting record date
- Sep 14, 2026
Commentary
AI commentary · Not investment advice
What happened
MEDICOX held an extraordinary shareholders' meeting and approved changing its name to CHOONGANG OCEAN Co., LTD. Inside directors Park Man-seon, Kang Byeong-nam and Jeong Su-jeong and independent director Nam Gi-hun were elected. A director pay limit of KRW 1.5 billion and an auditor pay limit of KRW 100.0 million were approved. The election of inside director Kim Jin-won was rejected. A proposal to move the head office was also rejected, so it stays in Seoul. An articles amendment on the number of directors failed in both its revised and original forms.
In the company's terms
Shares present totaled 1,940,863, or 35.2% of 5,517,785 voting shares. Approved items won 99.6% of the shares voted. The rejected director election and head office move won 51.5%.
What changes for shareholders
The board now has 4 inside directors and 3 outside directors, 7 in total. The company said it will change its stock name after registering the new corporate name.
Show Korean comments
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist